![Erle T. Mast](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erle T. Mast
Nessuna posizione attualmente
Profilo
Erle T.
Mast is the founder of Clovis Oncology, Inc. (founded in 2009), where he held the title of Chief Financial Officer, Secretary & Executive VP from 2012 to 2016.
He also held former positions as an Independent Director at Somaxon Pharmaceuticals, Inc. (2008-2013), Director at Verus Pharmaceuticals, Inc. (2007-2009), Independent Director at Zogenix, Inc. (2008-2022), Independent Director at Receptos LLC (2014-2015), Independent Director at Sienna Biopharmaceuticals, Inc. (2017-2018), Vice President-Finance at Dura Pharmaceuticals, Inc. (1997-2000), Chief Financial Officer & Executive Vice President at Pharmion Corp.
(2002-2008), and CFO-Global Biopharmaceuticals Business Unit at Elan Pharma International Ltd. (2000-2002).
Mr. Mast's education history includes an undergraduate degree from California State University-Bakersfield.
Precedenti posizioni note di Erle T. Mast
| Società | Posizione | Fine |
|---|---|---|
| ZOGENIX, INC. | Direttore/Membro del Consiglio | 07/03/2022 |
| SIENNA BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 02/08/2018 |
| CLOVIS ONCOLOGY, INC. | Fondatore | 31/03/2016 |
| RECEPTOS INC | Direttore/Membro del Consiglio | 27/08/2015 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Direttore/Membro del Consiglio | 01/01/2013 |
Formazione di Erle T. Mast
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Verus Pharmaceuticals, Inc.
 Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pediatric-oriented pharmaceutical products | Health Technology |
Elan Pharma International Ltd.
 Elan Pharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
California State University-Bakersfield
 California State University-Bakersfield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
